Chemoinformaics analysis of 2-Hydroxybutanoic acid
| Molecular Weight | 104.105 | nRot | 2 |
| Heavy Atom Molecular Weight | 96.041 | nRig | 1 |
| Exact Molecular Weight | 104.047 | nRing | 0 |
| Solubility: LogS | 0.384 | nHRing | 0 |
| Solubility: LogP | -0.416 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 14.4203 |
| nHD | 2 | BPOL | 8.89366 |
| QED | 0.454 |
| Synth | 2.956 |
| Natural Product Likeliness | 0.465 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.639 |
| HIA | 0.013 |
| CACO-2 | -4.582 |
| MDCK | 0.00208582 |
| BBB | 0.448 |
| PPB | 0.208336 |
| VDSS | 0.778 |
| FU | 0.822648 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.273 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.407 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.185 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.22 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.056 |
| CL | 3.312 |
| T12 | 0.907 |
| hERG | 0.011 |
| Ames | 0.092 |
| ROA | 0.09 |
| SkinSen | 0.678 |
| Carcinogencity | 0.086 |
| EI | 0.986 |
| Respiratory | 0.266 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.965083 |